Drug Resistance in Biofilm and Planktonic Cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia Clinical Isolates
Microbial Drug Resistance · 01.09.2024 · 30 (9) · 354-362
DOI: 10.1089/mdr.2023.0301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Drug Resistance, online erschienen am 06.09.2024. Verfasst von Edeer Iván Montoya-Hinojosa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departament of Microbiology, School of Biological Sciences, Autonomous University of Nuevo Leon, Avenida Pedro de Alba, San Nicolás de los Garza, Mex…. Hauptthemen laut MEDLINE: Biofilms, Stenotrophomonas maltophilia, Microbial Sensitivity Tests, Anti-Bacterial Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Background
Biofilm production in nonfermenting Gram-negative bacteria influences drug resistance. The aim of this work was to evaluate the effect of different antibiotics on biofilm eradication of clinical isolates of Achromobacter , Burkholderia , and Stenotrophomonas maltophilia .
Methods
Clinical isolates were identified by matrix-assisted laser desorption ionization–time of flight mass spectrometry in a third-level hospital in Monterrey, Mexico. Crystal violet staining was used to determine biofilm production. Drug susceptibility testing was determined by broth microdilution in planktonic cells and biofilm cells.
Results
Resistance in planktonic cells was moderate to trimethoprim-sulfamethoxazole, and low to chloramphenicol, minocycline, levofloxacin ( S. maltophilia and Burkholderia ), ceftazidime, and meropenem ( Burkholderia and Achromobacter ). Biofilm eradication required higher drug concentrations of ceftazidime, chloramphenicol, levofloxacin, and trimethoprim-sulfamethoxazole than planktonic cells ( p < 0.05). Levofloxacin showed biofilm eradication activity in S. maltophilia, minocycline and meropenem in Burkholderia , and meropenem in Achromobacter .
Conclusions
Drug resistance increased due to biofilm production for some antibiotics, particularly ceftazidime and trimethoprim-sulfamethoxazole for all three pathogens, chloramphenicol for S. maltophilia and Burkholderia, and levofloxacin for Burkholderia. Some antibiotics could be used for the treatment of biofilm-associated infections in our population, such as levofloxacin for S. maltophilia, minocycline and meropenem for Burkholderia , and meropenem for Achromobacter .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departament of Microbiology, School of Biological Sciences, Autonomous University of Nuevo Leon, Avenida Pedro de Alba, San Nicolás de los Garza, Mexico.
- Department of Infectious Diseases, University Hospital "Dr. José E. González" and School of Medicine, Autonomous University of Nuevo Leon, Avenida Madero S/N esq Avenida Gonzalitos, Mitras Centro, Monterrey, Mexico.
ORCID-Profile: Samantha Flores-Treviño
Zitieren
APA
Montoya-Hinojosa, E. I., Villarreal-Treviño, L., Bocanegra-Ibarias, P., Camacho-Ortiz, A., & Flores-Treviño, S. (2024). Drug Resistance in Biofilm and Planktonic Cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia Clinical Isolates. Microbial Drug Resistance, 30(9), 354-362. https://doi.org/10.1089/mdr.2023.0301
Vancouver
Montoya-Hinojosa EI, Villarreal-Treviño L, Bocanegra-Ibarias P, Camacho-Ortiz A, Flores-Treviño S. Drug Resistance in Biofilm and Planktonic Cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia Clinical Isolates. Microbial Drug Resistance. 2024;30(9):354-362. doi:10.1089/mdr.2023.0301
BibTeX
@article{MontoyaHinojosa2024,
author = {Montoya-Hinojosa, Edeer Iván and Villarreal-Treviño, Licet and Bocanegra-Ibarias, Paola and Camacho-Ortiz, Adrián and Flores-Treviño, Samantha},
title = {Drug Resistance in Biofilm and Planktonic Cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia Clinical Isolates},
journal = {Microbial Drug Resistance},
year = {2024},
volume = {30},
number = {9},
pages = {354--362},
doi = {10.1089/mdr.2023.0301}
}
EUVIMED